Literature DB >> 11712964

Lipid and acute-phase protein alterations in HIV-1 infected patients in the early stages of infection: correlation with CD4+ lymphocytes.

A Treitinger, C Spada, L M da Silva, E M Hermes, J A Amaral, D S Abdalla.   

Abstract

Lipid and acute-phase protein alterations have been described in various infection diseases, and they have been recorded during the early stages of HIV infection. Lipid and acute-phase protein profiles also have been correlated with cellular immunological abnormalities. To document these correlations during HIV infection, we studied 75 HIV-infected patients and 26 HIV-negative controls. Patients were classified according to the criteria proposed by the Walter Reed Army Institute: as WR-1 (CD4 lymphocytes, 1154 +/- 268/mm3), WR-2 (CD4, 793 +/- 348/mm3) and WR3/4 (CD4, 287+/-75 mm3). Triglycerides, total cholesterol and HDL-cholesterol concentrations were measured by enzymatic methods. Immunoglobulins (IgA and IgG) and acute-phase proteins (haptoglobin, alpha1-acid glycoprotein, C-reactive protein and transferrin) were determined by immunonephelometry. Haptoglobin levels were significantly increased in HIV-positive patients and correlated with the progression of HIV-infection (control<WR1<WR2<WR3/4). WR-2 and WR-3/4 patients had lower total cholesterol, HDL-cholesterol, and albumin concentrations, however, alpha1-acid glycoprotein and IgA levels were higher, when compared to HIV-negative controls. Elevated triglyceride levels (1.51+/-0.75 mmol/L) were found only in WR3/4 patients, when compared to the control individuals (1.05+/-0.04 mmol/L). No differences were found in transferrin and C-reactive protein concentrations among the studied groups. CD4+ lymphocyte counts were inversely correlated with triglycerides, IgA, alpha1-acid glycoprotein and haptoglobin, and they were positively correlated with albumin, total cholesterol and HDL-cholesterol. Multiple linear regression analysis showed that increased haptoglobin and IgA levels were the best predictive variables of a decreasing CD4+ lymphocyte count. In conclusion, our data showed that: 1) a decrease in total cholesterol, HDL-cholesterol and albumin levels occurred earlier than hypertriglyceridemia in the course of HIV infection; 2) increased levels of haptoglobin occurred earlier than that of alpha1-acid glycoprotein and IgA; 3) haptoglobin and IgA were the best predictive variables of a decreasing CD4+ lymphocyte count. Decreases in HDL-cholesterol and albumin levels with increases in haptoglobin, alpha1-acid glycoprotein, IgA, and triglycerides levels are indications of disease progression in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712964     DOI: 10.1590/s1413-86702001000400005

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  13 in total

1.  Lipid profile in HIV/AIDS patients in Nigeria.

Authors:  O O Adewole; S Eze; Ye Betiku; E Anteyi; I Wada; Z Ajuwon; G Erhabor
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

2.  A Study to Evaluate Lipid Profile in Treatment Naïve HIV Positive Patients.

Authors:  Anitha Devanath; Somdattaa Ray; Ravi Kumar; B S Prarthana
Journal:  Indian J Clin Biochem       Date:  2013-01-20

3.  Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon.

Authors:  Aissatou Abba; Joseph Fokam; Rachel Simo Kamgaing; Junie Flore Yimga; Aude Christelle Ka'e; Alex Durand Nka; Michel Carlos Tommo Tchouaket; Collins Ambe Chenwi; Ezechiel Ngoufack Jagni Semengue; Alexis Ndjolo; Samuel Martin Sosso
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

4.  Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.

Authors:  Livio Azzoni; Andrea S Foulkes; Cynthia Firnhaber; Xiangfan Yin; Nigel J Crowther; Deborah Glencross; Denise Lawrie; Wendy Stevens; Emmanouil Papasavvas; Ian Sanne; Luis J Montaner
Journal:  J Int AIDS Soc       Date:  2011-07-29       Impact factor: 5.396

5.  Acute phase response to Mycoplasma haemofelis and 'Candidatus Mycoplasma haemominutum' infection in FIV-infected and non-FIV-infected cats.

Authors:  R M Korman; J J Cerón; T G Knowles; E N Barker; P D Eckersall; S Tasker
Journal:  Vet J       Date:  2012-07-02       Impact factor: 2.688

6.  Total antioxidant potential and essential trace metals in the breast milk and plasma of Nigerian human immunodeficiency virus-infected lactating mothers.

Authors:  Sheu K Rahamon; Ganiyu O Arinola; Moses O Akiibinu
Journal:  J Res Med Sci       Date:  2013-01       Impact factor: 1.852

7.  Changes in Lipid Profiles and Other Biochemical Parameters in HIV-1 Infected Patients Newly Commenced on HAART Regimen.

Authors:  Ballah Akawu Denue; Mohammed Bashir Alkali; Ali Usman Abjah; Ibrahim Musa Kida; Babajide Ajayi; Bala Zira Fate
Journal:  Infect Dis (Auckl)       Date:  2013-03-06

Review 8.  Serum lipids and lipoproteins in malaria--a systematic review and meta-analysis.

Authors:  Benjamin J Visser; Rosanne W Wieten; Ingeborg M Nagel; Martin P Grobusch
Journal:  Malar J       Date:  2013-12-07       Impact factor: 2.979

9.  Determination of dehydroepiandrosterone and its biologically active oxygenated metabolites in human plasma evinces a hormonal imbalance during HIV-TB coinfection.

Authors:  María Belén Vecchione; Javier Eiras; Guadalupe Verónica Suarez; Matías Tomás Angerami; Cecilia Marquez; Omar Sued; Graciela Ben; Héctor Miguel Pérez; Diego Gonzalez; Patricia Maidana; Viviana Mesch; María Florencia Quiroga; Andrea Claudia Bruttomesso
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

10.  Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.

Authors:  Ceereena Ubaida-Mohien; Benjamin Lamberty; Alex M Dickens; Michelle M Mielke; Thomas Marcotte; Ned Sacktor; Igor Grant; Scott Letendre; Donald Franklin; Pawel Cibrowski; Ravi Tharakan; Justin C McArthur; Howard Fox; Norman J Haughey
Journal:  AIDS       Date:  2017-06-19       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.